ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 178 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $846,000 | -19.4% | 18,631 | -18.8% | 0.04% | -20.8% |
Q3 2019 | $1,050,000 | +320.0% | 22,931 | +256.7% | 0.05% | +231.2% |
Q4 2018 | $250,000 | -74.4% | 6,429 | -74.0% | 0.02% | -59.0% |
Q1 2018 | $976,000 | -34.1% | 24,729 | -43.3% | 0.04% | -40.9% |
Q4 2017 | $1,482,000 | – | 43,629 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |